David Domzalski - Sep 30, 2025 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Mutya Harsch, Attorney-in-Fact
Stock symbol
VYNE
Transactions as of
Sep 30, 2025
Transactions value $
-$4,246
Form type
4
Date filed
10/2/2025, 05:05 PM
Previous filing
Jul 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Domzalski David PRESIDENT AND CEO, Director C/O VYNE THERAPEUTICS INC., 685 ROUTE 202/206 N, SUITE 301, BRIDGEWATER /s/ Mutya Harsch, Attorney-in-Fact 2025-10-02 0001727794

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$4.25K -12.7K -2.87% $0.34 429K Sep 30, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.